CF INDUSTRIES HOLDINGS INC (CF)
US1252691001 - Common Stock
64.81 +1.9 (+3.02%)
Fundamental Rating
Overall CF gets a fundamental rating of 8 out of 10. We evaluated CF against 119 industry peers in the Chemicals industry. CF scores excellent points on both the profitability and health parts. This is a solid base for a good stock. A decent growth rate in combination with a cheap valuation! Better keep an eye on CF. This makes CF very considerable for value investing!.
Profitability
Profitability Rating
CF has a Return On Assets of 22.56%. This is amongst the best returns in the industry. The industry average is 7.93%. CF outperforms 96% of its industry peers.
CF has a Return On Equity of 55.44%. This is amongst the best returns in the industry. The industry average is 18.96%. CF outperforms 95% of its industry peers.
CF has a Profit Margin of 29.26%. This is amongst the best returns in the industry. The industry average is 9.39%. CF outperforms 91% of its industry peers.
The Piotroski-F score of CF is 8.00. This is a very strong score and indicates great health and profitability for CF.
VS Industry
ROA (22.56%) VS Industry: 96% outperformed.
0.50
281.32
ROE (55.44%) VS Industry: 95% outperformed.
0.68
73.26
Profit Margin (29.26%) VS Industry: 91% outperformed.
0.63
4,753.05
Valuation
Valuation Rating
With a Price/Earnings Ratio of 4.14, the valuation of CF can be described as very cheap.
Compared to an average industry Price/Earning Ratio of 12.11, CF is valued rather cheaply. On top of this CF is cheaper than 88% of the companies listed in the same industry.
With a Forward Price/Earnings Ratio of 7.84, the valuation of CF can be described as cheap.
CF's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
Compared to an average Enterprise Value to EBITDA ratio of 9.89, CF is valued rather cheaply. On top of this, CF has a better ratio than 94% of the companies listed in the same industry.
With a price book ratio of 2.32, CF is valued correctly.
When comparing the price book ratio of CF to the average industry price book ratio of 1.87, CF is valued more expensive than its industry peers.
VS Industry
Price/Earnings (4.14) VS Industry: 88% outperformed.
151.36
0.79
Price/Book (2.32) VS Industry: 39% outperformed.
883.27
0.05
Enterprise Value/ EBITDA (2.16) VS Industry: 94% outperformed.
30.79
0.11
Growth
Growth Rating
The Earnings Per Share has grown by an impressive 101.29% over the past year.
Measured over the past 5 years, CF shows a very strong growth in Earnings Per Share. The EPS has been growing by 60.68% on average per year.
Looking at the last year, CF shows a very strong growth in Revenue. The Revenue has grown by 23.59%.
CF shows a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 22.05% yearly.
Based on estimates for the next 5 years, CF will show a decrease in Revenue. The Revenue will decrease by -9.59% on average per year.
The Earnings Per Share is expected to decrease by -14.32% on average over the next 5 years. This is quite bad
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | 60.68% | 100.91% | 101.29% | -40.11% | -30.18% | -26.27% | -14.32% |
| Revenue | 22.05% | 34.57% | 23.59% | -35.02% | -22.27% | -17.54% | -9.59% |
Health
Health Rating
CF has a Current Ratio of 4.46. This indicates that CF is financially healthy and has no problem in meeting its short term obligations.
CF is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 2.05. CF has a better rating than 85% of its industry peers.
A Quick Ratio of 3.97 indicates that CF has no problem at all paying its short term obligations.
The Quick Ratio of CF is much better than the industry average of 1.32. CF has a better rating than 86% of its industry peers.
An Altman-Z score of 3.59 indicates that CF is not in any danger for bankruptcy at the moment.
The Altman-Z score of CF is much better than the industry average of 2.53.
The Piotroski-F score of CF is 8.00. This is a very strong score and indicates great health and profitability for CF.
The Debt to Equity ratio of CF is in line with the industry averages.
VS Industry
Debt/Equity (0.54) VS Industry: 50% outperformed.
22.82
0.00
Quick Ratio (3.97) VS Industry: 86% outperformed.
0.01
28.09
Current Ratio (4.46) VS Industry: 85% outperformed.
0.01
31.90
Altman-Z (3.59) VS Industry: 72% outperformed.
-529.47
117.74
Dividend
Dividend Rating
10.62% of the earnings are spent on dividend by CF. This is a low number and sustainable payout ratio.
CF has been paying a dividend for at least 10 years, so it has a reliable track record.
CF has a Yearly Dividend Yield of 2.66%. Purely for dividend investing, there may be better candidates out there.
The stock price of CF dropped by -26.98% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CF's Dividend Yield is comparable with the industry average which is at 2.64.
Compared to an average S&P500 Dividend Yield of 2.71, CF has a dividend comparable with the average S&P500 company.
The dividend of CF has a limited annual growth rate of 4.78%.
The Dividend Rate of CF has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
VS Industry
Dividend Yield (2.66%) VS Industry: 52% outperformed.
0.34
38.75
CF INDUSTRIES HOLDINGS INC
NYSE:CF (6/5/2023, 10:05:08 AM)
64.81
+1.9 (+3.02%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-01 2023-05-01/amc
Earnings (Next)07-31 2023-07-31/amc
Inst Owners91.2%
Inst Owner Change-3.22%
Ins Owners0.49%
Ins Owner Change16.59%
Market Cap12.63B
Analysts73.79
Price Target89.71 (38.42%)
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.66% |
Dividend Growth(5Y)4.78%
DP10.62%
Div Incr Years1
Div Non Decr Years6
Ex-Date05-12 2023-05-12 (0.4)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.9%
Min EPS beat(2)-3.41%
Max EPS beat(2)13.22%
EPS beat(4)1
Avg EPS beat(4)-6.09%
Min EPS beat(4)-33.87%
Max EPS beat(4)13.22%
Revenue beat(2)1
Avg Revenue beat(2)-2.34%
Min Revenue beat(2)-10.75%
Max Revenue beat(2)6.06%
Revenue beat(4)1
Avg Revenue beat(4)-3.61%
Min Revenue beat(4)-10.75%
Max Revenue beat(4)6.06%
PT rev (1m)-7.93%
PT rev (3m)-20.5%
EPS NQ rev (1m)-17.69%
EPS NQ rev (3m)-30.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-30.68%
Revenue NQ rev (1m)-7.02%
Revenue NQ rev (3m)-19.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.14 | ||
| Fwd PE | 7.84 | ||
| P/S | 1.22 | ||
| P/FCF | 4.28 | ||
| P/OCF | 3.7 | ||
| P/B | 2.32 | ||
| P/tB | 3.76 | ||
| EV/EBITDA | 2.16 |
EPS(TTM)15.64
EY24.13%
EPS(NY)8.26
Fwd EY12.75%
FCF(TTM)15.14
FCFY23.37%
OCF(TTM)17.5
OCFY27%
SpS53
BVpS27.98
TBVpS17.26
PEG (NY)N/A
PEG (5Y)0.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 22.56% | ||
| ROE | 55.44% | ||
| ROIC | 30.24% | ||
| ROICexc | 39.03% | ||
| ROICexgc | 49.73% | ||
| OM | 46.18% | ||
| PM | 29.26% | ||
| GM | 48.65% |
ROA(3y)11.73%
ROA(5y)8.3%
ROE(3y)35.23%
ROE(5y)26.5%
ROIC(3y)18.75%
ROIC(5y)13.5%
ROICexc(3y)22.56%
ROICexc(5y)15.88%
ROICexgc(3y)28.84%
ROICexgc(5y)20.3%
ROICexcg growth 3Y87.67%
ROICexcg growth 5Y95.84%
ROICexc growth 3Y88.48%
ROICexc growth 5Y95.69%
OM growth 3Y34.76%
OM growth 5Y54.45%
PM growth 3Y40.69%
PM growth 5Y28.11%
GM growth 3Y27%
GM growth 5Y37.9%
F-Score8
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 1 | ||
| Debt/EBITDA | 0.53 | ||
| Cap/Depr | 54.13% | ||
| Profit Quality | 97.65% | ||
| Current Ratio | 4.46 | ||
| Quick Ratio | 3.97 | ||
| Altman-Z | 3.59 |
F-Score8
WACC9.06%
ROIC/WACC5.49
Cap/Depr(3y)48.61%
Cap/Depr(5y)47.9%
Profit Quality(3y)216.59%
Profit Quality(5y)248.76%
Growth
EPS 1Y101.29%
EPS 3Y100.91%
EPS 5Y60.68%
EPS growth Q2Q-31.12%
EPS Next Y-40.11%
EPS Next 2Y-30.18%
EPS Next 3Y-26.27%
EPS Next 5Y-14.32%
Revenue growth 1Y23.59%
Revenue growth 3Y34.57%
Revenue growth 5Y22.05%
Revenue growth Q2Q-29.85%
Revenue Next Year-35.02%
Revenue Next 2Y-22.27%
Revenue Next 3Y-17.54%
Revenue Next 5Y-9.59%
EBIT growth 1Y33.05%
EBIT growth 3Y81.35%
EBIT growth 5Y88.51%
EBIT Next Year-40.59%
EBIT Next 3Y-22.11%
EBIT Next 5Y-13.61%
FCF growth 1Y145.18%
FCF growth 3Y45.65%
FCF growth 5Y24.05%
OCF growth 1Y124.85%
OCF growth 3Y36.82%
OCF growth 5Y18.77%
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA